Higher-Risk MDS Satellite Symposium

Video

Sponsored

Program chair Navel Daver, MD, invites you to PER®’s complimentary in-person and virtual satellite symposium.

Join Navel Daver, MD, and other leading experts at PER’s Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials on June 4, 2022.

Related Videos
Findings from a study highlight that 7/8 mismatched unrelated donor posttransplant cyclophosphamide may be a suitable alternative treatment option for those with graft-vs-host disease.
Related Content